Our data suggest that maternal HFD is associated with epigenetic alterations in EphB2, VWF, Ppargc1β and Fgf21 that may contribute to the pathogenesis of NASH. This evidence concerns the gene PPARGC1B and metabolic dysfunction-associated steatohepatitis.